SARS-CoV-2 serology by mild symptoms of disease

Completed

• Conditions: SARS-CoV-2 infection; 10047438

• Registration Number: NL-OMON50020
• Lead Sponsor: Medlon b.v. Medische Diagnostiek

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-12-09
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 39

Inclusion Criteria

18 years or older
Abliity to read and understand informed consent
Proven SARS-CoV-2 infection more than three weeks ago.
No hospitalisation for more than three month
No clinical symptoms of active infection at the time of bloodsampling

Exclusion Criteria

age of 17 years or younger
Unable to read the informed consent

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Sensitivity of the diverse assays in a population of patients with mild<br /><br>symptoms.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>